ClinicalTrials.gov
public full text
Public Domain
suPAR Michigan M2C2 Heterogeneity Validation Cohort Study
acute-respiratory-distress-syndromebiomarkercovid-19mechanical-ventilationreal-world-datarespiratory-failure
This is a retrospective, non interventional cohort study using stored plasma samples from appoximately 300 adults hospitalized with confirmed COVID 19. Baseline suPAR measured using the suPARnostic TurbiLatex assay on the Roche cobas c501.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers#1046119
- Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness#1362717
- Postpartum Screening of Type 2 Diabetes#860929
- Multi-Center Registry for ME/CFS#828848
- Plasma Neprilysin for Predicting Sepsis Within 48 Hours in ICU Patients With Infection or Suspected Infection#1451467
Record · ID 1475916
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive